HCSGD entry for IFNAR1
1. General information
Official gene symbol | IFNAR1 |
---|---|
Entrez ID | 3454 |
Gene full name | interferon (alpha, beta and omega) receptor 1 |
Other gene symbols | AVP IFN-alpha-REC IFNAR IFNBR IFRC |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in PPI subnetwork.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0004904 | Interferon receptor activity | IEA | molecular_function |
GO:0004905 | Type I interferon receptor activity | TAS | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005886 | Plasma membrane | TAS | cellular_component |
GO:0005887 | Integral component of plasma membrane | TAS | cellular_component |
GO:0007166 | Cell surface receptor signaling pathway | TAS | biological_process |
GO:0007259 | JAK-STAT cascade | TAS | biological_process |
GO:0009615 | Response to virus | TAS | biological_process |
GO:0019221 | Cytokine-mediated signaling pathway | TAS | biological_process |
GO:0032729 | Positive regulation of interferon-gamma production | IEA | biological_process |
GO:0042110 | T cell activation | IEA | biological_process |
GO:0045351 | Type I interferon biosynthetic process | IEA | biological_process |
GO:0051607 | Defense response to virus | IEA | biological_process |
GO:0060337 | Type I interferon signaling pathway | TAS | biological_process |
GO:0060338 | Regulation of type I interferon-mediated signaling pathway | TAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0276430607 | 0.9928741271 | 0.3857863203 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.0784722094 |
GSE13712_SHEAR | Up | 0.0897869721 |
GSE13712_STATIC | Down | -0.0027894933 |
GSE19018 | Up | 0.0444511721 |
GSE19899_A1 | Up | 0.0127575025 |
GSE19899_A2 | Up | 0.3503986561 |
PubMed_21979375_A1 | Up | 0.3937538267 |
PubMed_21979375_A2 | Up | 0.2902955729 |
GSE35957 | Up | 0.3397244903 |
GSE36640 | Up | 0.8663721550 |
GSE54402 | Down | -0.0241558867 |
GSE9593 | Up | 0.3294686351 |
GSE43922 | Up | 0.4098074991 |
GSE24585 | Up | 0.3534870392 |
GSE37065 | Up | 0.0982962868 |
GSE28863_A1 | - | - |
GSE28863_A2 | - | - |
GSE28863_A3 | - | - |
GSE28863_A4 | - | - |
GSE48662 | Up | 0.4141017373 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
Peginterferon alfa-2a | DB00008 | BTD00043 | BIOD00043 |
Interferon alfa-n1 | DB00011 | BTD00096 | BIOD00096 | DB00084 |
Interferon alfa-n3 | DB00018 | BTD00023 | BIOD00023 |
Peginterferon alfa-2b | DB00022 | BTD00048 | BIOD00048 |
Interferon beta-1a | DB00060 | BTD00093 | BIOD00093 |
Interferon beta-1b | DB00068 | BTD00078 | BIOD00078 |
Interferon alfacon-1 | DB00069 | BTD00062 | BIOD00062 |
Interferon Alfa-2b, Recombinant | DB00105 | BTD00066 | BIOD00066 |
Natural alpha interferon | DB05258 | - |
omega interferon | DB05472 | - |
- MicroRNAs
- mirTarBase
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-98-5p | MIMAT0000096 | MIRT027659 | Microarray | Functional MTI (Weak) | 19088304 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
- mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 2 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
27052162 | Inactivation of the IFN pathway is mediated by the IFN receptor IFNAR1 downregulation that invariably occurs during melanoma development |
27052162 | These results suggest that IFN signaling is an important tumor-suppressive pathway that inhibits melanoma development and progression and argue for targeting IFNAR1 downregulation to prevent metastatic disease and improve the efficacy of molecularly target and immune-targeted melanoma therapies |
26046815 | Furthermore, neutralization of endogenous IFN or genetic ablation of its receptor chain IFNAR1 compromises the recognition of senescent cells and their clearance in vitro and in vivo |
Entries Per Page
Displaying Page of